Use of antibody-drug conjugate

TW202641600APending Publication Date: 2026-10-16DAIICHI SANKYO CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115116912
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-12-11
Filing Date
2019-12-10
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001081398_001
    Figure TWG2TA001081398_001
  • Figure TWG2TA001081398_002
    Figure TWG2TA001081398_002
  • Figure TWG2TA001081398_003
    Figure TWG2TA001081398_003
Patent Text Reader

Abstract

An antibody-drug conjugate is used in the manufacture of a drug for treating cancer, wherein the antibody-drug conjugate is combined with a PARP inhibitor and administered, wherein the antibody-drug conjugate is bound to an antibody via a thioether bond by a drug linker as shown in the following formula (where A represents the binding site with the antibody), wherein the antibody in the antibody-drug conjugate is an anti-B7-H3 antibody.
Need to check novelty before this filing date? Find Prior Art